Monoclonal antibodies specific for oncofetal antigen – immature laminin receptor protein: Effects on tumor growth and spread in two murine models

Humoral Immune Responses against the Immature Laminin Receptor Protein Show Prognostic Significance in Patients with Chronic Lymphocytic Leukemia

(2014) Birte Friedrichs et al.   JOURNAL OF IMMUNOLOGY

Laminin Receptor 37/67LR Regulates Adhesion and Proliferation of Normal Human Intestinal Epithelial Cells

(2013) Taoufik Khalfaoui et al.   PLoS One

Anti-LRP/LR-Specific Antibody IgG1-iS18 Significantly Reduces Adhesion and Invasion of Metastatic Lung, Cervix, Colon and Prostate Cancer Cells

(2012) Aadilah Omar et al.   JOURNAL OF MOLECULAR BIOLOGY

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial

(2010) M Hallek et al.   LANCET

High expression of the immature laminin receptor protein correlates with mutated IGVH status and predicts a favorable prognosis in chronic lymphocytic leukemia

(2010) Birte Friedrichs et al.   LEUKEMIA RESEARCH

Production, safety and antitumor efficacy of recombinant Oncofetal Antigen/immature laminin receptor protein

(2009) Adel L. Barsoum et al.   BIOMATERIALS

Treatment of chronic myeloid leukemia in blast crisis

(2008) R. Hehlmann et al.   HAEMATOLOGICA

Invasion of Tumorigenic HT1080 Cells Is Impeded by Blocking or Downregulating the 37-kDa/67-kDa Laminin Receptor

(2008) Chantal Zuber et al.   JOURNAL OF MOLECULAR BIOLOGY

In-vivo detectable antibodies directed against the oncofetal antigen/immature laminin receptor can recognize and control myeloma cells—clinical implications

(2008) S Siegel et al.   LEUKEMIA